In this study, the investigators are going to investigate the efficacy of choline alfoscerate on improvement of cognitive function assessed by MMSE compared to plaebo.
The investigators will enroll patients with type 2 diabetes whose age is equal to higher than 60, and randomly assigned study drug or placebo at 1:1 ratio. The treatment duration is 6 months and extension study will be continued to 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
36
Treatment duration is 6 months and can be extended to 12 months with participant's agreement.
Treatment duration is 6 months and can be extended to 12 months with participant's agreement.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Cognitive function
Change of MMSE Score
Time frame: 6 months
Glucose metabolism
Changes in HbA1c
Time frame: 6 months
Glucose metabolism
Changes in fasting glucose concentration
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.